CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS. MAJMHS. 2025;1(8):51-63. Accessed January 30, 2026. https://usajournals.org/index.php/1/article/view/1362